A Study of Immune Responses to the Virus That Causes COVID-19 (CoVPN 5001)
A Prospective Study of Acute Immune Responses to SARSCoV-2 Infection
Sponsor: COVID-19 Prevention Network
This observational or N/A phase trial investigates COVID-19 and SARS-CoV-2 and is currently completed. COVID-19 Prevention Network leads this study, which shows 16 recorded versions since 2020 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2022 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2022 — Sep 2022 [monthly]
Active Not Recruiting
-
Oct 2021 — Jan 2022 [monthly]
Active Not Recruiting
▶ Show 11 earlier versions
-
Sep 2021 — Oct 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting
-
Mar 2021 — May 2021 [monthly]
Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2020 — Dec 2020 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- COVID-19 Prevention Network
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .